Volume Replacement Therapy during Hip Arthroplasty using Hydroxyethyl Starch (130/0.4) Compared to Lactated Ringer Decreases Allogeneic Blood Transfusion and Postoperative Infection

Jones, 2003, The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers, Anesth Analg, 96, 363, 10.1213/00000539-200302000-00012 Lang, 2001, Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery, Anesth Analg, 93, 405 Boldt, 2000, Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass, J Cardiothorac Vasc Anesth, 14, 264, 10.1053/cr.2000.5857 Karanko, 1987, Restoring volume by crystalloid versus colloid after coronary artery bypass: hemodynamics, lung water, oxygenation, and outcome, Crit Care Med, 15, 559, 10.1097/00003246-198706000-00004 Boldt, 1993, Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass, Anesth Analg, 76, 1185, 10.1213/00000539-199376060-00002 Haisch, 2001, Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients, J Cardiothorac Vasc Anesth, 15, 316, 10.1053/jcan.2001.23276 Gallandat, 2000, A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery, Can J Anesth, 47, 1207, 10.1007/BF03019870 Grauer, 2001, Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study, Critical Care, 5, S115, 10.1186/cc1182 Langeron, 2001, Voluven® a lower substituted novel hydroxyethylstarch (HES 130/0.4) causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5, Anesth Analg, 92, 855, 10.1097/00000539-200104000-00011 Gandhi, 2007, Volume replacement therapy during major orthopedic surgery using Voluven® (hydroxyethyl starch 130/0.4) or hetastarch, Anesthesiol, 106, 1120, 10.1097/01.anes.0000265422.07864.37 Hébert, 1999, A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group, N Engl J Med, 340, 409, 10.1056/NEJM199902113400601 Taylor, 2006, Red blood cell transfusions and nosocomial infections in critically ill patients, Crit Care Med, 34, 2302, 10.1097/01.CCM.0000234034.51040.7F Hladik, 2006, Transmission of Human Herpesvirus 8 by Blood Transfusion, New Engl J Med, 355, 1331, 10.1056/NEJMoa055009 Innerhofer, 1999, Transfusion of buffy coatdepleted blood components and risk of postoperative infection in orthopedic patients, Transfusion, 39, 625, 10.1046/j.1537-2995.1999.39060625.x Spiess, 2007, Red cell transfusions and Guidelines: a work in progress, Hematol Oncol Clin North Am, 21, 185, 10.1016/j.hoc.2006.11.006 D’Ambrosio, 1999, Reducing perioperative blood loss in patients undergoing total hip arthroplasty, Int J Artif Organs, 22, 47, 10.1177/039139889902200110 Lentschener, 1999, Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion, Anesth Analg, 89, 590, 10.1213/00000539-199909000-00009 Finfer, 2004, A comparison of albumin and saline for fluid resuscitation in the intensive care unit, N Engl J Med, 350, 2247, 10.1056/NEJMoa040232 Cardinal, 1980, The electronic aggregometer: a novel device for assessing platelet behavior in blood, J Pharmacol Methods, 3, 135, 10.1016/0160-5402(80)90024-8 Bernard, 1994, The American-European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination, AmJ Respir Crit Care Med, 149, 818, 10.1164/ajrccm.149.3.7509706 Thygesen, 2007, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction – Universal definition of myocardial infarction, J Am Coll Cardiol, 50, 2173, 10.1016/j.jacc.2007.09.011 Haase, 2009, A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery – associated acute kidney injury, J Thorac Cardiovasc Surg, 138, 1370, 10.1016/j.jtcvs.2009.07.007 Despotis, 1999, Optimal management of bleeding and transfusion in patients undergoing cardiac surgery, Semin Thorac Cardiovasc Surg, 11, 84, 10.1016/S1043-0679(99)70002-X Levy, 2003, SCCM/ESICM/ACCP/ATS/SIS – 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, Crit Care Med, 31, 1250, 10.1097/01.CCM.0000050454.01978.3B Riley, 1995, Prevention of hypotension after spinal anesthesia for cesarean section: six percent hetastarch versus lactated Ringer's solution, Anesth Analg, 81, 838 Hartog, 2011, The efficacy and safety of colloid resuscitation in the critically ill, Anesth Analg, 112, 156, 10.1213/ANE.0b013e3181eaff91 Langdown, 2000, Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty, J Arthroplasty, 15, 1009, 10.1054/arth.2000.8102 Ellger, 2002, High dose volume replacement using HES 130/0.4 during major surgery does not alter coagulation, Europ J of Anaesth, 19, 297 Rosencher, 2003, Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe, Transfusion, 43, 459, 10.1046/j.1537-2995.2003.00348.x Holcomb, 2004, Methods for improved hemorrhage control, Crit Care, 8, S57, 10.1186/cc2407 Fraga, 2005, Evidence for myocardial defects under extreme acute normovolemic hemodilution with hydroxyethyl starch and lactated Ringer's solution, Shock, 24, 388, 10.1097/01.shk.0000180617.21564.b3 Margarido, 2007, Pulmonary function is better preserved in pigs when acute normovolemic hemodilution is achieved with hydroxyethyl starch versus lactated Ringer's solution, Shock, 27, 390, 10.1097/01.shk.0000245026.01365.55 Otsuki, 2007, Hydroxyethyl starch is superior to lactated Ringer as a replacement fluid in a pig model of acute normovolaemic haemodilution, Br J Anaesth, 98, 29, 10.1093/bja/ael312 Ruttmann, 2002, Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery, Br J Anaesth, 89, 226, 10.1093/bja/aef179 Kozek-Langenecker, 2006, In vitro testing of haemostatic sideeffects of colloids, Acta Anaesthesiol Scand, 50, 518, 10.1111/j.1399-6576.2005.00843.x Thyes, 2006, Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs, Anesthesiol, 105, 1228, 10.1097/00000542-200612000-00023 Davies, 2006, Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model, Health Technol Assess, 10, ix Jones, 2003, The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers, Anesth Analg, 96, 363, 10.1213/00000539-200302000-00012 Lang, 2001, Colloids versus crystalloids and tissue oxygen tension in patients undergoing major abdominal surgery, Anesth Analg, 93, 405 Boldt, 2000, Volume therapy with a new hydroxyethyl starch solution in cardiac surgical patients before cardiopulmonary bypass, J Cardiothorac Vasc Anesth, 14, 264, 10.1053/cr.2000.5857 Karanko, 1987, Restoring volume by crystalloid versus colloid after coronary artery bypass: hemodynamics, lung water, oxygenation, and outcome, Crit Care Med, 15, 559, 10.1097/00003246-198706000-00004 Boldt, 1993, Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass, Anesth Analg, 76, 1185, 10.1213/00000539-199376060-00002 Haisch, 2001, Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients, J Cardiothorac Vasc Anesth, 15, 316, 10.1053/jcan.2001.23276 Gallandat, 2000, A novel hydroxyethyl starch (Voluven®) for effective perioperative plasma volume substitution in cardiac surgery, Can J Anesth, 47, 1207, 10.1007/BF03019870 Grauer, 2001, Effects on general safety and coagulation after long-term, high-dose volume therapy with 6% hydroxyethyl starch 130/0.4 in patients with acute ischemic stroke. Results of a randomized, placebo-controlled, double-blind study, Critical Care, 5, P115, 10.1186/cc1182 Langeron, 2001, Voluven® a lower substituted novel hydroxyethylstarch (HES 130/0.4) causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5, Anesth Analg, 92, 855, 10.1097/00000539-200104000-00011 Gandhi, 2007, Volume replacement therapy during major orthopedic surgery using Voluven® (hydroxyethyl starch 130/0.4) or hetastarch, Anesthesiol, 106, 1120, 10.1097/01.anes.0000265422.07864.37 Hébert, 1999, A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group, N Engl J Med, 340, 409, 10.1056/NEJM199902113400601 Taylor, 2006, Red blood cell transfusions and nosocomial infections in critically ill patients, Crit Care Med, 34, 2302, 10.1097/01.CCM.0000234034.51040.7F Hladik, 2006, Transmission of Human Herpesvirus 8 by Blood Transfusion, New Engl J Med, 355, 1331, 10.1056/NEJMoa055009 Innerhofer, 1999, Transfusion of buffy coatdepleted blood components and risk of postoperative infection in orthopedic patients, Transfusion, 39, 625, 10.1046/j.1537-2995.1999.39060625.x Spiess, 2007, Red cell transfusions and Guidelines: a work in progress, Hematol Oncol Clin North Am, 21, 185, 10.1016/j.hoc.2006.11.006 D’Ambrosio, 1999, Reducing perioperative blood loss in patients undergoing total hip arthroplasty, Int J Artif Organs, 22, 47, 10.1177/039139889902200110 Lentschener, 1999, Reduction of blood loss and transfusion requirement by aprotinin in posterior lumbar spine fusion, Anesth Analg, 89, 590, 10.1213/00000539-199909000-00009 Finfer, 2004, A comparison of albumin and saline for fluid resuscitation in the intensive care unit, N Engl J Med, 350, 2247, 10.1056/NEJMoa040232 Cardinal, 1980, The electronic aggregometer: a novel device for assessing platelet behavior in blood, J Pharmacol Methods, 3, 135, 10.1016/0160-5402(80)90024-8 Bernard, 1994, The American- European Consensus Conference on ARDS: definitions, mechanisms, relevant outcomes, and clinical trial coordination, AmJ Respir Crit Care Med, 149, 818, 10.1164/ajrccm.149.3.7509706 Thygesen, 2007, Joint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial Infarction – Universal definition of myocardial infarction, J Am Coll Cardiol, 50, 2173, 10.1016/j.jacc.2007.09.011 Haase, 2009, A comparison of the RIFLE and Acute Kidney Injury Network classifications for cardiac surgery – associated acute kidney injury, J Thorac Cardiovasc Surg, 138, 1370, 10.1016/j.jtcvs.2009.07.007 Despotis, 1999, Optimal management of bleeding and transfusion in patients undergoing cardiac surgery, Semin Thorac Cardiovasc Surg, 11, 84, 10.1016/S1043-0679(99)70002-X Levy, 2003, SCCM/ESICM/ACCP/ATS/SIS – 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference, Crit Care Med, 31, 1250, 10.1097/01.CCM.0000050454.01978.3B Riley, 1995, Prevention of hypotension after spinal anesthesia for cesarean section: six percent hetastarch versus lactated Ringer's solution, Anesth Analg, 81, 838 Hartog, 2011, The efficacy and safety of colloid resuscitation in the critically ill, Anesth Analg, 112, 156, 10.1213/ANE.0b013e3181eaff91 Langdown, 2000, Aprotinin (Trasylol) does not reduce bleeding in primary total hip arthroplasty, J Arthroplasty, 15, 1009, 10.1054/arth.2000.8102 Ellger, 2002, High dose volume replacement using HES 130/0.4 during major surgery does not alter coagulation, Europ J of Anaesth, 19, 297 Rosencher, 2003, Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe, Transfusion, 43, 459, 10.1046/j.1537-2995.2003.00348.x Holcomb, 2004, Methods for improved hemorrhage control, Crit Care, 8, S57, 10.1186/cc2407 Fraga, 2005, Evidence for myocardial defects under extreme acute normovolemic hemodilution with hydroxyethyl starch and lactated Ringer's solution, Shock, 24, 388, 10.1097/01.shk.0000180617.21564.b3 Margarido, 2007, Pulmonary function is better preserved in pigs when acute normovolemic hemodilution is achieved with hydroxyethyl starch versus lactated Ringer's solution, Shock, 27, 390, 10.1097/01.shk.0000245026.01365.55 Otsuki, 2007, Hydroxyethyl starch is superior to lactated Ringer as a replacement fluid in a pig model of acute normovolaemic haemodilution, Br J Anaesth, 98, 29, 10.1093/bja/ael312 Ruttmann, 2002, Effects on coagulation of intravenous crystalloid or colloid in patients undergoing peripheral vascular surgery, Br J Anaesth, 89, 226, 10.1093/bja/aef179 Kozek-Langenecker, 2006, In vitro testing of haemostatic sideeffects of colloids, Acta Anaesthesiol Scand, 50, 518, 10.1111/j.1399-6576.2005.00843.x Thyes, 2006, Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs, Anesthesiol, 105, 1228, 10.1097/00000542-200612000-00023 Davies, 2006, Cost-effectiveness of cell salvage and alternative methods of minimising perioperative allogeneic blood transfusion: a systematic review and economic model, Health Technol Assess, 10, 1, 10.3310/hta10440